Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α

被引：0

作者：

De Ridder, K. ^{[1
]}

Locy, H. ^{[1
]}

Piccioni, E. ^{[1
]}

Zuazo, M. Ibarra ^{[2
]}

Awad, R. M. ^{[1
]}

Verhulst, S. ^{[3
,4
]}

van Bulck, M. ^{[5
]}

De Vlaeminck, Y. ^{[1
]}

Lecocq, Q. ^{[1
]}

Reijmen, E. ^{[1
]}

De Mey, W. ^{[1
]}

De Beck, L.

Ertveldt, T. ^{[1
]}

Pintelon, I. ^{[6
]}

Timmermans, J-P. ^{[6
]}

Escors, D. ^{[2
]}

Keyaerts, M. ^{[7
]}

Breckpot, K. ^{[1
]}

Goyvaerts, C. ^{[1
]}

机构：

[1] Vrije Univ Brussel, Fac Med & Pharm, Dept Biomed Sci, Lab Mol & Cellular Therapy, Brussels, Belgium

[2] Navarrabiomed UPNA IdISNA, Immunomodulat Grp, Pamplona, Spain

[3] Dept Biomed Sci, Brussels, Belgium

[4] Liver Cell Biol Res Grp, Jette, Belgium

[5] Vrije Univ Brussel, Dept Biomed Sci, Lab Mol & Med Oncol, Jette, Belgium

[6] Univ Antwerp, Antwerp Ctr Adv Microscopy ACAM, Lab Cell Biol & Histol, Antwerp, Belgium

[7] Vrije Univ Brussel, Fac Med & Pharm, Invivo Cellular & Mol Imaging Lab, Jette, Belgium

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.02.200

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

168P

引用

页码：S109 / S109

页数：1

共 50 条

[31] Redirecting Chemotherapeutics to the Endoplasmic Reticulum Increases Tumor Immunogenicity and Potentiates Anti-PD-L1 Therapy
Xiang, Yucheng
Chen, Liqiang
Liu, Chendong
Yi, Xiaoli
Li, Lian
Huang, Yuan
SMALL, 2022, 18 (06)
[32] Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
Boustani, Jihane
Lecoester, Benoit
Baude, Jeremy
Latour, Charlene
Adotevi, Olivier
Mirjolet, Celine
Truc, Gilles
CANCERS, 2021, 13 (19)
[33] Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies
Heskamp, Sandra
Hobo, Willemijn
Molkenboer-Kuenen, Janneke D. M.
Olive, Daniel
Oyen, Wim J. G.
Dolstra, Harry
Boerman, Otto C.
CANCER RESEARCH, 2015, 75 (14) : 2928 - 2936
[34] ANTI-PD-L1/IL-15 KD033 ACTIVATED MACROPHAGES AND INDUCED ANTI-TUMOR IMMUNITY IN THE TUMOR-MICROENVIRONMENT
Martomo, Stella
Wang, George
Polonskaya, Zhanna
Luna, Xenia
Lu, Dan
Patel, Jeegar
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A681 - A681
[35] Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma
Liang, Jiahua
Ma, Mingjian
Feng, Wei
Xu, Qiongcong
Chen, Dong
Lai, Jiaming
Chen, Jiancong
APOPTOSIS, 2024, : 55 - 68
[36] Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer
Yuan, M.
Zhai, Y. R.
Hui, Z.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S126 - S126
[37] Tumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responses
Li, Yafei
Liu, Yi
Kang, Zhengjun
Guo, Jianhua
Liu, Nan
SCIENTIFIC REPORTS, 2023, 13 (01):
[38] Tumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responses
YaFei Li
Yi Liu
Zhengjun Kang
Jianhua Guo
Nan Liu
Scientific Reports, 13 (1)
[39] Anlotinib enhances the antitumor activity of high-dose irradiation combined with anti-PD-L1 by potentiating the tumor immune microenvironment in murine lung cancer
Yuan, M.
Zhai, Y.
Hui, Z.
ANNALS OF ONCOLOGY, 2022, 33 : S114 - S114
[40] Anlotinib enhances the antitumor activity of high-dose irradiation combined with anti-PD-L1 by potentiating the tumor immune microenvironment in murine lung cancer
Yuan, M.
Zhai, Y.
Hui, Z.
ANNALS OF ONCOLOGY, 2022, 33 : S15 - S15

← 1 2 3 4 5 →